Argan, Inc.
AGX
$331.03
+0.22%
Argan, Inc. is a holding company whose subsidiaries (GPS, APC, TRC, and SMC) provide engineering, procurement, construction, commissioning, and maintenance services primarily to the power generation market, including natural gas-fired and renewable energy facilities, along with industrial fabrication and teledata infrastructure work in the U.S., Ireland, and the U.K. Argan is a niche, specialized EPC contractor rather than a diversified mega-cap builder, and its competitive identity rests on deep gas-turbine power plant expertise that positions it as a key enabler of the AI data center build-out. The investor narrative has swung violently over the past year: bulls point to a multi-year backlog driven by surging electricity demand from AI data centers and natural gas turbine orders, while bears argue project awards have peaked, capacity constraints limit incremental growth, and industrial segment margins remain soft. Recent headlines capture this tension — a Q2 earnings and revenue beat in early September 2026 was quickly followed by a nearly 8% single-day selloff after an analyst initiated coverage with an Underweight rating citing peak-cycle concerns, leaving the stock in a sharp debate over whether it is a structural growth story or a late-cycle contractor.…
AGX
Argan, Inc.
$331.03
Related headlines
Investment Opinion: Should I buy AGX Today?
Rating: Hold. Argan's explosive revenue growth (50.2% YoY) and fortress balance sheet are offset by peak-cycle concerns, a shrinking backlog, and a severe stock price decline (-57% from 52-week high). The analyst consensus is mixed, with an average target price of $570.50, implying 65.1% upside, but the lack of a clear recommendation (recommendation: 'none') and a recent Underweight initiation suggest caution. Supporting evidence includes a low forward PE of 21.5x and PEG of 0.60, which are attractive relative to growth, but the trailing PE of 34.7x and EV/EBITDA of 27.6x are rich. Free cash flow of $486.9M is strong, and margins are expanding. However, the industrial segment remains soft, and backlog contraction raises questions about future revenue. Risks include capacity constraints, potential peak in project awards, and valuation compression. The rating would upgrade to Buy if backlog re-accelerates and industrial margins improve, or downgrade to Sell if revenue growth falls below 20% or backlog continues to shrink. The stock appears fairly valued to slightly undervalued relative to its growth prospects, but the risk/reward is balanced given the uncertain cycle.
Sign up to view all
AGX 12-Month Price Forecast
Argan presents a compelling growth story with strong fundamentals, but the market is pricing in a cyclical peak. The stock's sharp decline and cautious analyst commentary suggest that near-term upside may be limited until backlog growth resumes. The low forward PE and PEG ratio provide a margin of safety, but the high trailing multiples and capacity constraints are concerns. We would upgrade to bullish if backlog stabilizes and new awards are announced, and downgrade to bearish if revenue growth falls below 10% or margins contract significantly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Argan, Inc.'s 12-month outlook, with a consensus price target around $570.50 and implied upside of +72.3% versus the current price.
Average Target
$570.50
0 analysts
Implied Upside
+72.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$273 - $785
Analyst target range
Bulls vs Bears: AGX Investment Factors
The bull case rests on Argan's explosive 50% revenue growth, fortress balance sheet, and strategic position in the AI data center power build-out, supported by a low PEG of 0.60. However, the bear case has gained the upper hand recently, evidenced by a 57% decline from the 52-week high, an Underweight initiation citing peak-cycle concerns, and a shrinking backlog. The most critical tension is whether the current project awards represent a cyclical peak or a durable multi-year runway; resolution of this debate will dictate whether the stock recovers or continues to de-rate. Near-term, the bears have stronger evidence given the negative price momentum and cautious analyst commentary, but the long-term growth story remains intact if backlog re-accelerates.
Bullish
- Explosive revenue growth: Q1 FY2027 revenue surged 50.2% YoY to $290.95M, up from $193.66M in Q1 FY2026. This acceleration, driven by the power services segment, demonstrates Argan's ability to capture surging demand from AI data center power infrastructure.
- Fortress balance sheet: Debt-to-equity is just 0.0138 and the current ratio is 1.60, indicating virtually no leverage and ample liquidity. This financial flexibility allows Argan to fund working capital for large EPC projects without diluting shareholders.
- Margin expansion underway: Gross margin improved to 21.0% in Q1 FY2027 from 19.0% a year earlier, while operating margin rose to 15.6% from 12.6%. Net margin reached 15.8%, up from 11.6%, reflecting better project execution and operating leverage.
- Attractive PEG and forward PE: The PEG ratio of 0.60 and forward PE of 21.5x suggest the stock is inexpensive relative to expected earnings growth. Trailing PE of 34.7x is elevated, but the forward multiple implies analysts expect EPS to more than double.
Bearish
- Severe stock price collapse: AGX has plunged 57.1% from its 52-week high of $805.75 to $345.56, with a 3-month decline of 37.3% and a 6-month drop of 42.2%. This sharp sell-off reflects growing skepticism about the sustainability of the cycle.
- Peak-cycle concerns and capacity constraints: An analyst initiated coverage with an Underweight rating, citing capacity constraints and a peak in project awards, triggering an 8% single-day drop. The market fears Argan may struggle to grow backlog further given limited engineering and construction resources.
- Soft industrial margins and shrinking backlog: Despite the Q2 beat, industrial segment margins remained soft and backlog contracted, raising questions about revenue visibility beyond the current power projects. This mix shift could pressure overall profitability if power awards slow.
- Extreme valuation multiples: Price-to-book is 10.4x and EV/EBITDA is 27.6x, both well above typical engineering & construction peers. The market is pricing in sustained high growth, leaving little room for disappointment.
AGX Technical Analysis
Beta
0.55
0.55x market volatility
Max Drawdown
-58.6%
Largest decline past year
52-Week Range
$276-$806
Price range past year
Annual Return
+19.9%
Cumulative gain past year
| Period | AGX Return | S&P 500 |
|---|---|---|
| 1m | -11.6% | -1.0% |
| 3m | -41.8% | +2.9% |
| 6m | -49.3% | +6.5% |
| 1y | +19.9% | +13.1% |
| ytd | +1.6% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AGX Fundamental Analysis
Quarterly Revenue
$290954000.0B
2026-04
Revenue YoY Growth
+50.2%
YoY Comparison
Gross Margin
21.0%
Latest Quarter
Free Cash Flow
$486894000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AGX Overvalued?
PE
34.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 10x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are relatively low given Argan's debt-to-equity of 0.0138 and current ratio of 1.60, but the company faces margin pressure from soft industrial segment performance and a shrinking backlog. Revenue is highly concentrated in the power services segment, which, while currently strong, could be vulnerable to a slowdown in project awards. Additionally, the trailing PE of 34.7x and EV/EBITDA of 27.6x leave little room for earnings misses, as evidenced by the 8% single-day drop on an analyst downgrade. Market and competitive risks include valuation compression if growth decelerates; the stock trades at 10.4x book and 5.1x sales, well above historical norms for EPC contractors. The beta of 0.55 suggests lower market correlation, but the stock has severely underperformed the S&P 500 over the past 3 and 6 months (relative strength of -40.0% and -49.7%, respectively), indicating sector-specific headwinds. Regulatory risks are minimal, but competition from larger EPC firms and potential shifts in energy policy could impact demand. The worst-case scenario involves a continued decline in project awards, backlog contraction, and margin compression, leading to a drop toward the 52-week low of $257.62, which represents a 25.5% downside from the current price of $345.56. If analyst bear-case target of $273 is realized, the downside is 21.0%. A more severe scenario, such as a recession reducing power demand, could push the stock below $250, a 27.6% loss.
FAQ
The most severe risk is a cyclical peak in project awards, which could lead to a shrinking backlog and revenue decline, as highlighted by the recent Underweight rating. Financial risks are low due to minimal debt (D/E 0.0138), but margin pressure from soft industrial segments could compress profitability. Competitive risks include larger EPC firms encroaching on Argan's niche, and macro risks such as a slowdown in data center spending could reduce demand. Valuation risk is also high, with trailing multiples elevated; any earnings miss could trigger a sharp sell-off, as seen with the 8% drop on the analyst downgrade.
Our 12-month forecast has a base case (50% probability) of $400-$570, assuming moderate growth and stable backlog. The bull case (25%) targets $570-$785 if new awards accelerate, while the bear case (25%) sees $257-$350 if backlog continues to shrink. The most likely scenario is the base case, with the key assumption that revenue growth decelerates to 15-20% but remains healthy. The wide range reflects the uncertainty around the cycle.
AGX trades at a trailing PE of 34.7x and EV/EBITDA of 27.6x, which are premium multiples for an EPC contractor, but the forward PE of 21.5x and PEG of 0.60 suggest undervaluation relative to expected earnings growth. The market is pricing in high growth, as evidenced by the 10.4x price-to-book ratio. Compared to peers, AGX's valuation is rich on trailing metrics but reasonable on forward earnings. The stock appears fairly valued to slightly undervalued given its growth prospects, but the premium leaves little room for error.
AGX offers a compelling risk/reward for growth investors, with a forward PE of 21.5x and a PEG of 0.60, implying significant upside if growth continues. The average analyst target of $570.50 suggests 65% upside, but the recent Underweight initiation and 57% decline from highs highlight peak-cycle risks. The biggest downside risk is a continued backlog contraction, which could push the stock to the 52-week low of $257.62, a 25% loss. For long-term investors comfortable with volatility, AGX is a good buy on dips, but near-term uncertainty warrants caution.
AGX is more suitable for long-term investors with a horizon of at least 2-3 years, given the cyclical nature of its business and the current uncertainty around project awards. The low beta of 0.55 suggests lower volatility than the market, but the stock has experienced a max drawdown of -56.7%, indicating significant risk. Short-term trading is risky due to the potential for sharp moves on news. A minimum holding period of 2 years is recommended to ride out the cycle and benefit from the AI data center build-out.